医療レポート：Breast Cancer-疫学予測（～2022）...市場調査レポートについてご紹介

1 Table of Contents
1 Table of Contents 4
1.1 List of Tables 6
1.2 List of Figures 7
2 Introduction 8
2.1 Catalyst 8
2.2 Upcoming Reports 9
3 Epidemiology 10
3.1 Disease Background 10
3.2 Risk Factors and Comorbidities 11
3.2.1 A family history of breast cancer and BRCA1/2 gene mutations significantly increase the breast cancer risk 12
3.2.2 Reproductive hormonal factors influence the risk of breast cancer 13
3.2.3 Modifiable lifestyle-related factors increase the risk of mortality in breast cancer patients 15
3.2.4 Screening programs have been shown to reduce breast cancer mortality, although the benefits need to be carefully weighed against the risks 17
3.3 Global Trends 19
3.3.1 Incidence 19
3.3.2 Prevalence and Survival 26
3.4 Forecast Methodology 31
3.4.1 Sources Used 33
3.4.2 Sources Not Used 38
3.4.3 Forecast Assumptions and Methods 39
3.5 Epidemiological Forecast for Breast Cancer (2012-2022) – Incident Cases 43
3.5.1 Incident Cases of Breast Cancer 43
3.5.2 Age-Specific Incident Cases of Breast Cancer 45
3.5.3 Incident Cases of Breast Cancer by Menopausal Status 47
3.5.4 Incident Cases of Breast Cancer Segmented by Stage at Diagnosis 49
3.5.5 Age-Standardized Breast Cancer Incidence Rates 50
3.6 Epidemiological Forecast for Breast Cancer (2012-2022) — Prevalent Cases 52
3.6.1 Five-Year Prevalent Cases of Breast Cancer 52
3.6.2 Age-Specific Five-Year Prevalent Cases of Breast Cancer 54
3.6.3 Five-Year Prevalent Cases by Menopausal Status 55
3.6.4 Five-Year Prevalent Cases by Hormone Receptor Subtypes 56
3.7 Discussion 58
3.7.1 Epidemiological Forecast Insight 58
3.7.2 Limitations of the Analysis 60
3.7.3 Strengths of the Analysis 61
4 Appendix 63
4.1 Bibliography 63
4.2 About the Authors 73
4.2.1 Epidemiologists 73
4.2.2 Reviewers 73
4.2.3 Global Director of Epidemiology and Health Policy 75
4.2.4 Global Head of Healthcare 76
4.3 About GlobalData 77
4.4 About EpiCast 77
4.5 Disclaimer 78